Stephen Galli
Director/Board Member at ATOSSA THERAPEUTICS, INC.
Net worth: 150 $ as of 30/04/2024
Stephen Galli active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | 01/07/2011 | - |
| Independent Dir/Board Member | 01/07/2011 | - | |
| Stanford University School of Medicine | Corporate Officer/Principal | 01/02/1999 | - |
| Association of Pathology Chairs | President | - | - |
Career history of Stephen Galli
Former positions of Stephen Galli
| Companies | Position | Start | End |
|---|---|---|---|
| Collegium Internationale Allergologicum | President | 06/10/2010 | - |
American Society for Investigative Pathology
 American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | President | - | - |
Training of Stephen Galli
| Harvard Medical School | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| President | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Collegium Internationale Allergologicum | |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Health Technology |
| Association of Pathology Chairs |
- Stock Market
- Insiders
- Stephen Galli
- Experience